FDA Alert: Videx/Videx EC (didanosine): Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension
Links shared publicly online about this topic.
- 1,455total visits
FDA Alert: Videx/Videx EC (didanosine): Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension
FDA Alert: Videx/Videx EC (didanosine): Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension
View full resource at drugs.com
Tags: Heart Disease, High Blood Pressure, HIV Medication, FDA, Videx
Most Recently Shared on January 31, 2010 at 1:57 am By:
FDA Alert - FDA Warns of Non-Cirrhotic Portal Hypertension Risk in Patients Using Videx/Videx EC (didanosine) - http://bit.ly/cNElgB
Advertisement
